GGHC
NXTM
Gilder Gagnon Howe & Co’s NxStage Medical Inc. NXTM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-13,237
| Closed | -$369K | – | 298 |
|
2018
Q3 | $369K | Hold |
13,237
| – | – | ﹤0.01% | 247 |
|
2018
Q2 | $369K | Hold |
13,237
| – | – | ﹤0.01% | 243 |
|
2018
Q1 | $329K | Sell |
13,237
-115,313
| -90% | -$2.87M | ﹤0.01% | 254 |
|
2017
Q4 | $3.12M | Sell |
128,550
-1,447,749
| -92% | -$35.1M | 0.04% | 183 |
|
2017
Q3 | $43.5M | Sell |
1,576,299
-623,920
| -28% | -$17.2M | 0.61% | 51 |
|
2017
Q2 | $55.2M | Sell |
2,200,219
-2,755,411
| -56% | -$69.1M | 0.82% | 37 |
|
2017
Q1 | $133M | Sell |
4,955,630
-794,131
| -14% | -$21.3M | 2.24% | 5 |
|
2016
Q4 | $151M | Sell |
5,749,761
-140,948
| -2% | -$3.69M | 2.97% | 5 |
|
2016
Q3 | $147M | Sell |
5,890,709
-127,367
| -2% | -$3.18M | 2.53% | 5 |
|
2016
Q2 | $130M | Sell |
6,018,076
-29,938
| -0.5% | -$649K | 2.59% | 5 |
|
2016
Q1 | $90.7M | Buy |
6,048,014
+35,967
| +0.6% | +$539K | 1.78% | 12 |
|
2015
Q4 | $132M | Buy |
6,012,047
+827,097
| +16% | +$18.1M | 2.12% | 8 |
|
2015
Q3 | $81.8M | Buy |
5,184,950
+1,311,719
| +34% | +$20.7M | 1.3% | 20 |
|
2015
Q2 | $55.3M | Sell |
3,873,231
-64,902
| -2% | -$927K | 0.73% | 41 |
|
2015
Q1 | $68.1M | Sell |
3,938,133
-96,758
| -2% | -$1.67M | 0.95% | 37 |
|
2014
Q4 | $72.3M | Buy |
4,034,891
+284,964
| +8% | +$5.11M | 1.08% | 28 |
|
2014
Q3 | $49.2M | Sell |
3,749,927
-495,044
| -12% | -$6.5M | 0.72% | 39 |
|
2014
Q2 | $61M | Sell |
4,244,971
-44,858
| -1% | -$645K | 0.81% | 34 |
|
2014
Q1 | $54.7M | Buy |
+4,289,829
| New | +$54.7M | 0.74% | 43 |
|